Differential regulation of TRAIL and CD95 ligand in transformed cells of the T and B lymphocyte lineage

European Journal of Immunology

Volumn 28, Issue 3, 1998, Pages 973-982

  Mariani, Sara M ^a   Krammer, Peter H ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Apoptosis; CD95 (APO 1 Fas) ligand; Soluble ligand; Surface regulation; TRAIL

Indexed keywords

1,10 PHENANTHROLINE; ANTIBODY; CYSTEINE PROTEINASE; CYSTEINE PROTEINASE INHIBITOR; FAS LIGAND; LEUPEPTIN; LIGAND; METALLOPROTEINASE INHIBITOR; RECOMBINANT PROTEIN; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ANTIGEN ANTIBODY REACTION; APOPTOSIS; ARTICLE; B LYMPHOCYTE; CELL LINE; CELL TYPE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE TRANSFORMATION; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; B-LYMPHOCYTES; CELLS, CULTURED; CYSTEINE PROTEINASE INHIBITORS; ENZYME INHIBITORS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; HUMANS; MEMBRANE GLYCOPROTEINS; METALLOENDOPEPTIDASES; MICE; MOLECULAR WEIGHT; T-LYMPHOCYTES; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0031905817     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1521-4141(199803)28:03<973::AID-IMMU973>3.0.CO;2-T     Document Type: Article

References (35)

1. Krammer, P. H., Dhein, J., Walczak, H., Behrman, I., Mariani, S., Matiba, B., Fath, M., Daniel, P. T., Knipping, E., Westendorp, M. O., Stricker, K., Bäumler, C., Hellbardt, S., Germer, M., Peter, M. E. and Debatin, K-M., The role of APO-1 mediated apoptosis in the immune system, Immunol. Rev. 1994. 142: 175-191.
2. Nagata, S. and Golstein, P., The Fas death factor. Science 1995. 267: 1449-1455.
3. Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C. P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A. and Goodwin, R. G., Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity 1995. 3: 673-682.
4. Pitti, R. M., Marsters, S. A., Rupper, S., Donahue, C. J., Moore, A. and Ashkenazi, A., Induction of apoptosis by APO-2 ligand, a new member of the TNF cytokine family. J. Biol. Chem. 1996. 271: 12687-12690.
5. Boldin, M. P., Goncharov, T. M., Goltsev, Y. V. and Wallach, D., Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell 1996. 85: 803-815.
6. Muzio, M., Chinnaiyan, A. M., Kischkel, F. C., O'Rourke, K., Shevchenko, A., Ni, J., Scaffidi, C., Bretz, J. D., Zhang, M., Gentz, R., Mann, M., Krammer, P. H., Peter, M. E. and Dixit, V. M., FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell 1996. 85: 817-827.
7. Mariani, S. M., Matiba, B., Armandola, E. A. and Krammer, P. H., Interleukin 1b-converting enzyme-related proteases/caspases are involved in TRAIL-induced apoptosis of myeloma and leukemia cells. J. Cell Biol. 1997. 137: 221-229.
8. Suda, T., Okazaki, T., Naito, Y., Yokota, T., Arai, N., Ozaki, S., Nakao, K. and Nagat, S., Expression of the Fas ligand in cells of T cell lineage. J. Immunol. 1995. 154: 3806-3813.
9. Hanabuchi, S., Koyonagi, M., Kawasaki, A., Shinohara, N., Matsuzawa, A., Nishimura, Y., Kabayashi, Y., Yonehara, S., Yagita, H. and Okumura, K., Fas and its ligand in a general mechanism of T-cell mediated cytotoxicity. Proc. Natle. Acad. Sci. USA 1994. 91: 4930-4934.
10. Ju, S. T., Panka, D. J., Cui, H., Ettinger, R., EI-Khatib, M., Sherr, D. H., Stanger, B. Z. and Marshak-Rothstein, A., Fas(CD95)/FasL interactions required for programmed cell death after T-cell activation. Nature 1995. 373: 444-448.
11. Kägi, D., Vignaux, F., Lederman, B., Burkin, K., Depretere, V., Nagata, S., Hengartner, H. and Golstein, P., Fas and perforin pathway as major mechanisms of T-cell mediated cytotoxicity. Science 1994. 265: 528-530.
12. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J., Cytolytic T-cell cytotoxicity is mediated through perforin and Fas ligand pathways. Nature 1994. 370: 650-653.
13. + T cell-mediated cytotoxicity. J. Immunol. 1994. 152: 1127-1132.
14. Rothstein, T. L., Wang, J. K. M., Panka, D. J., Foote, L. C., Wang, Z., Stanger, B., Cui, H., Ju, S. and Marshak-Rothstein, A., Protection against Fas-dependent Th1-mediated apoptosis by antigen receptor engagement in B cells. Nature 1995. 374: 163-165.
15. Dhein, J., Walczak, H., Bäumler, C., Debatin, K.-M. and Krammer, P. H., Autocrine T-cell suicide mediated by APO-1/(Fas/CD95). Nature 1995. 373: 438-441.
16. Glass, A., Walsh, C. M., Lynch, D. H. and Clark, W. R., Regulation of the Fas lytic pathway in cloned CTL. J. Immunol. 1996. 156: 3638-3644.
17. Ozdemirli, M., EI-Khatib, M., Foote, L. C., Wang, J. K., Marshak-Rothstein, A., Rothstein, T. L. and Ju, S. T., Fas (CD95)/Fas ligand interactions regulate antigenspecific, MHC-restricted T/B cell proliferative responses. Eur. J. Immunol. 1996. 26: 415-419.
18. + T cell clones use perforin or Fas/Fas ligand-mediated pathways for target cell lysis. J. Immunol. 1997. 158: 2756-2761.
19. Montel, A. H., Bochan, M. R., Hobbs, J. A., Lynch, D. H. and Brahmi, Z., Fas involvement in cytotoxicity mediated by human NK cells. Cell. Immunol. 1995. 166: 236-246.
20. Arase, H., Arase, N. and Saito, T., Fas-mediated cytotoxicity by freshly isolated natural killer cells. J. Exp. Med. 1995. 181: 1235-1238.
21. Süss, G. and Shortman, K., A subclass of dendritic cells kill CD4 T cells via Fas/Fas-ligand induced apoptosis. J. Exp. Med. 1996. 183: 1789-1796.
22. Oyaizu, N., Adachi, Y., Hashimoto, F., McCloskey, T. W., Hosaka, N., Kayagaki, N., Yagita, H. and Pahwa, S., Monocytes express Fas ligand upon CD4 crosslinking and induce CD4 T cell apoptosis. J. Immunol. 1997. 158: 2456-2463.
23. Hahne, M., Renno, T., Schroeter, M., Irmler, M., French, L., Bornard, T., McDonald, H. R. and Tschopp, J., Activated B cells express functional Fas ligand. Eur. J. Immunol. 1996. 26: 721-724.
24. Mariani, S. M., Matiba, B., Bäumler, C. and Krammer, P. H., Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur. J. Immunol. 1995. 25: 2303-2307.
25. Kayagaki, N., Kawasaki, A., Ebata, T., Ohmoto, H, Ikeda, S., Inoue, S., Yoshino, K., Okumura, K. and Vagita, H., Metalloproteinase-mediated release of human Fas ligand. J. Exp. Med. 1995. 182: 1777-1783.
26. Tanaka, M., Suda, T., Haze, K., Nakamura, N., Sato, K., Kimura, F., Motoyoshi, K., Mizuki, M., Tagawa, S., Oliga, S., Hatake, K., Drummond, A. H. and Nagata, S., Fas ligand in human serum. Nature Med. 1996. 2: 317-322.
27. Tanaka, M., Suda, T., Takahashi, T. and Nagata, S., Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 1995. 14: 1129-1135.
28. Peitsch, M. and Tschopp, J., Comparative molecular modeling of the Fas-ligand and other members of the TNF family. Mol. Immunol. 1995. 32: 761-768.
29. Mariani, S. M., Matiba, B., Sparna, T. and Krammer, P. H., Expression of biologically active mouse and human CD95 (APO-1/Fas) ligand in the baculovirus system. J. Immunol. Methods 1996. 193: 63-70.
30. Solorzano, C. C., Ksontini, R., Pruitt, J. H., Hess, P. J., Edwards, P. D., Vauthey, J. N., Copeland, E. M., Edwards, C. K., Lauwers, G. Y., Clare-Salzler, M., MacKay, S., Moldawer, L. L. and Lazarus, D. D., Involvement of 26 KDa cell-associated TNF-a in experimental hepatitis and exacerbation of liver injury with a matrix metalloproteinase inhibitor. J. Immunol. 1997. 158: 414-419.
31. Black, R. A., Rauch, C. T., Kozlosky, C. J., Peschon, J. P., Slack, J. L., Wolfson, M. F., Castner, B. J., Stocking, K. L., Reddy, P., Srinivasan, S., Nelson, N., Boiani, N., Schooley, K. A., Gerhart, M., Davis, R., Fizner, J. N., Johnson, R. J., Paxton, R. J., March, C. J. and Cerretti, D. P., A metalloproteinase disintegrin that releases TNF-α from cells. Nature 1997. 385: 729-733.
32. Moss, M. L., Jin, S, L. C., Milla, M. E., Burkhart, W., Carter, H. L., Chen, W. J., Clay, W. C., Didsbury, J. R., Hassler, D., Hoffman, C. R., Kost, T. A., Lambert, M. R., Leesnitzer, M. A., McCauley, P., McGeehan, G., Mitchell, J., Moyer, M., Pahel, G., Rocque, W., Overton, L. K., Schoenen, F., Seaton, T., Su, J. L., Warner, J. L., Willard, D. and Becherer, J. D., Cloning of a disintegrin metalloproteinase that processes precursor tumor necrosis factor-alpha. Nature 1997. 385: 733-736.
33. Barret, A. J. and Rawlings, N. D., Families and clans of cysteine peptidases. Perspect. Drug Disc. Design 1996. 6: 1-11.
34. Katunuma, N. and Kominami, E., Structure, properties, mechanisms and assays of cysteine protease inhibitors: cystatins and E64 derivatives. Methods Enyzmol. 1995. 251: 383-397.
35. Mariani, S. M. and Krammer, P. H., Detection of active infection of Sf9 insect cells by recombinant baculoviruses. J. Virol. Methods 1998, in press.